Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» FDA delays decision on approving J&J's Risperdal Consta for bipolar disorder
FDA delays decision on approving J&J's Risperdal Consta for bipolar disorder
FDA delays decision on approving J&J's Risperdal Consta for bipolar disorder
Submitted by
admin
on February 11, 2009 - 7:09am
Source:
Yahoo/AP
News Tags:
FDA
JNJ
bipolar disorder
Risperdal Consta
Headline:
FDA delays decision on approving J&J's Risperdal Consta for bipolar disorder
Do Not Allow Advertisers to Use My Personal information
